FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older...
Redirecting to full article...
Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older...
Redirecting to full article...